Cocktails + Conversation: the SF Edition
We gathered our community of investors, corporate partners and entrepreneurs in San Francisco last week for our annual West Coast Cocktails and Conversation.
Executive Director Lindy Fishburne welcomed everyone to the event and 15 Breakout Labs Portfolio Companies took the stage to introduce themselves, explain their technology and chat about their recent milestones.
Bioelectric Devices is developing AI-driven therapeutic monitors that are accurate, affordable, and universally accessible to people living with diabetes and cardiometabolic disorders.
CalWave harnesses the renewable power of ocean waves to produce electricity and freshwater through its innovative, off-shore Wave Energy Converter.
In response to the FDA’s aggressive bans on classes of chemicals (such as antimicrobials), Curie Co couples recycled marine biomaterials and engineered proteins to deliver safer, sustainable antimicrobials for your favorite personal care products at a competitive price point.
DropGenie is developing a bench top machine that enables scientists to make meaningful changes to genomes.
Glyscend is developing a first-in-class, oral metabolic therapeutic which is restricted to the gastrointestinal lining and designed to mimic the benefits of bariatric surgery on type 2 diabetes and weight loss.
G-Tech Medical is creating the “EKG for the gut,” a wireless patch that measures the motor activity of digestive organs.
Inhalon is developing inhalable biotherapeutics for treatment and prevention of pulmonary diseases.
LogicInk makes temporary tattoo-like wearables that are electronics-free and transform to convey useful information about your body or the environment.
Napigen offers genome technologies for mitochondrial DNA to create broad business opportunities including the production of hybrid wheat in agriculture.
Nuclease Probe Technologies is redefining sepsis diagnosis by harnessing the power of bacterial proteins to enable the rapid treatment of bloodstream infections with appropriate antimicrobial therapy.
Orion BioScience is focused on advancing a Soluble Antigen Array (SAgA) platform into the clinic to intercept autoimmune disease by mimicking peripheral tolerance and restoring health.
SciBac designs microbial hybrids using its proprietary gene transfer technology to treat and prevent antibiotic resistant disease.
Seatrec is harvesting clean energy from temperature differences in the environment to provide power at remote off-grid locations.
3Scan and Transcriptic merged to form Strateos. Strateos automates chemical, biological and image analysis in a closed loop robotic laboratory, granting our partners the power to accelerate drug discovery programs.
UbiQD produces very bright quantum dots (QDs) with a scalable, low-cost process using environmentally friendly synthesis that is free of toxic heavy metals and/or other carcinogenic materials. These QDs are deployed in greenhouses, to improve the quality of sunlight and boost crop yield.
After the presentations, cocktails and conversations resumed, meaningful connections were made and everyone enjoyed themselves. Thank you for joining us for a night of science, technology and networking.
